Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

NCT02698579 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Adrenoleukodystrophy (CALD)
Adrenoleukodystrophy (ALD)
X-Linked Adrenoleukodystrophy (X-ALD)

Interventions

GENETIC: No interventional drug product utilized in this follow-up study

Sponsor

Genetix Biotherapeutics Inc.